The company would be a fool to defend itself by saying that it never actually committed to a hard date.
It has consistently been leading the SHs into believing that it will resubmit the BLA by 30 June 2024.
If it wasn't submitted by 30 June - they should disclose per listing rule 3.1
If it was submitted - there is no reason why they should wait for FDA's acceptance letter. They can announce resubmission now, and back it up further with another announcement when the FDA accepts the resubmission.
The company would be a fool to defend itself by saying that it...
-
- There are more pages in this discussion • 1,867 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.49 | $1.44 | $3.472M | 2.379M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12398 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 5440 | 3 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |